You are currently on the new version of our website. Access the old version .
  • Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
  • Article
  • Open Access

6 June 2009

QSAR Study on 6-Substituted Benzimidazoles: An Insight into the Structural Requirement for the Angiotensin II AT1 Receptor Antagonist

and
1
Nahata College of Pharmacy, Rajiv Gandhi Technical University, Mhow-Neemuch Road 458001 Mandasur (M.P.), India
2
School of Pharmacy, Devi Ahilya VishawaVidalaya, Takshashila Parser Khandawa Road, 452003 Indore (M.P.), India
*
Author to whom correspondence should be addressed.

Abstract

With an aim to identify the structural requirements for selective AT1 angiotensin antagonistic activity, a quantitative structure activity relationship (QSAR) analysis was carried out on a series of 6-substituted benzimidazole derivatives. The QSAR expressions were generated using 28 compounds and the predictive ability of the resulting model was evaluated against a test set of 12 compounds. The internal (cross validated squared correlation coefficient) and external consistency (predictive correlation coefficient) of the QSAR model was 0.78 and 0.40 respectively. In the present work QSAR analysis reveals that geometrical, structural, and shape descriptors govern the angiotensin II AT1 antagonistic activity.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.